NO782230L - Fremgangsmaate ved fremstilling av n-amidino-3,5-diamino-6-substituert-2-pyrazincarboxamid - Google Patents

Fremgangsmaate ved fremstilling av n-amidino-3,5-diamino-6-substituert-2-pyrazincarboxamid

Info

Publication number
NO782230L
NO782230L NO782230A NO782230A NO782230L NO 782230 L NO782230 L NO 782230L NO 782230 A NO782230 A NO 782230A NO 782230 A NO782230 A NO 782230A NO 782230 L NO782230 L NO 782230L
Authority
NO
Norway
Prior art keywords
diamino
amidino
mol
preparation
pyrazinecarboxamide
Prior art date
Application number
NO782230A
Other languages
English (en)
Norwegian (no)
Inventor
Otto William Woltersdorf Jr
Susan Jane Desolms
Edward Jethro Cragoe Jr
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO782230L publication Critical patent/NO782230L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02—Acyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Liquid Crystal Substances (AREA)
NO782230A 1977-06-29 1978-06-28 Fremgangsmaate ved fremstilling av n-amidino-3,5-diamino-6-substituert-2-pyrazincarboxamid NO782230L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/811,011 US4196292A (en) 1977-06-29 1977-06-29 6-Substituted amiloride derivatives

Publications (1)

Publication Number Publication Date
NO782230L true NO782230L (no) 1979-01-02

Family

ID=25205286

Family Applications (1)

Application Number Title Priority Date Filing Date
NO782230A NO782230L (no) 1977-06-29 1978-06-28 Fremgangsmaate ved fremstilling av n-amidino-3,5-diamino-6-substituert-2-pyrazincarboxamid

Country Status (12)

Country Link
US (1) US4196292A (pl)
EP (1) EP0000200B1 (pl)
JP (1) JPS5412389A (pl)
AT (1) AT362795B (pl)
DE (1) DE2861684D1 (pl)
DK (1) DK290278A (pl)
ES (1) ES471244A1 (pl)
FI (1) FI781966A7 (pl)
HU (1) HU178302B (pl)
IT (1) IT1105454B (pl)
NO (1) NO782230L (pl)
PL (1) PL119097B1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4362724A (en) * 1980-05-19 1982-12-07 Merck & Co., Inc. Method of treating edema and hypertension and pharmaceutical composition therefor in which the active ingredient comprises a novel substituted pyrazinyl-1,2,4-oxadiazole and a kaliuretic diuretic
US4952582A (en) * 1982-01-04 1990-08-28 Beyer Jr Karl H Pyrazinoylguanidine and derivatives thereof having few polar substituents and being useful as hyperuretic agents
US4594349A (en) * 1982-01-04 1986-06-10 Beyer Jr Karl H Hyperuretic agents
WO1990009792A1 (en) * 1989-03-03 1990-09-07 The General Hospital Corporation Topical application of amiloride or analogues thereof for treatment of inflammation
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6858614B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenolic guanidine sodium channel blockers
US6903105B2 (en) * 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
US20090253714A1 (en) * 2003-08-20 2009-10-08 Johnson Michael R Methods of reducing risk of infection from pathogens
US20070021439A1 (en) * 2005-07-25 2007-01-25 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
PE20151054A1 (es) 2012-12-17 2015-08-07 Parion Sciences Inc Derivados de cloro-pirazin carboxamida con actividad bloqueadora sobre los canales de sodio epiteliales
MX2015007797A (es) 2012-12-17 2015-10-05 Parion Sciences Inc Compuestos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil) carbamimidoil) pirazin-2-carboxamida.
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB286896A (en) * 1927-03-29 1928-03-15 Arthur William Howarth Improvements in smokers' pipes
US3305552A (en) * 1965-11-22 1967-02-21 Merck & Co Inc 3-aminopyrazinoic acids and process for their preparation
US3507865A (en) * 1967-04-27 1970-04-21 Merck & Co Inc 3-hydroxy- and 3-mercaptopyrazinamidoguanidines the corresponding ethers and thioethers and processes for their preparation
US3573306A (en) * 1969-03-05 1971-03-30 Merck & Co Inc Process for preparation of n-substituted 3,5-diamino-6-halopyrazinamides

Also Published As

Publication number Publication date
DK290278A (da) 1978-12-30
DE2861684D1 (en) 1982-04-29
AT362795B (de) 1981-06-10
US4196292A (en) 1980-04-01
JPS5412389A (en) 1979-01-30
PL119097B1 (en) 1981-11-30
IT1105454B (it) 1985-11-04
FI781966A7 (fi) 1978-12-30
IT7849984A0 (it) 1978-06-22
ES471244A1 (es) 1979-10-01
EP0000200A1 (en) 1979-01-10
EP0000200B1 (en) 1982-03-24
HU178302B (en) 1982-04-28
ATA469078A (de) 1980-11-15
PL207947A1 (pl) 1979-10-22

Similar Documents

Publication Publication Date Title
SU628820A3 (ru) Способ получени производных 4,5,6,7-тетрагидротиено(2,3-с) пиридина
SU820659A3 (ru) Способ получени производных 4-амино- 5-АлКилСульфОНилОАНизАМидОВ, иХ СОлЕй,ОКиСЕй, лЕВО- и пРАВОВРАщАющиХизОМЕРОВ /иХ ВАРиАНТы/
CN112707836B (zh) 一种间二酰胺类化合物的制备方法
EP1674456B1 (en) Use of 2-fluoro- 3-ketoesters for preparing 3-fluoro-6,7,8,9-tetrahydro-4-H-pyrimdo[1,2-a]pyrimidin-4-ones
NO122814B (pl)
CN107445909B (zh) 一种丙硫菌唑中间体的制备方法
US4196292A (en) 6-Substituted amiloride derivatives
EP0171739B1 (en) Imidazo[1,5-a]pyrimidine derivatives and process for their preparation
NO167046B (no) Fremgangsmaate for ekstraksjon av metall og nye ekstraksjonsmidler.
NO773300L (no) Fremgangsmaate for fremstilling av nye eddiksyrederivater
JP2002529462A (ja) ラセミ化方法
RU2044737C1 (ru) Производные 2,3-дигидропирано[2,3-b]пиридина или их соли, способ их получения 2-аминометил-2,3-дигидропирано(2,3-b)пиридина в качестве исходного вещества для получения производных 2,3-дигидропирано[2,3-b]пиридина и способ его получения
US4939164A (en) Strontium salt
JPS5973579A (ja) ベンゾフラン又はベンゾチオフェン誘導体，この化合物を有効成分とする尿酸排泄剤及びその製造方法
CA2004911A1 (en) 4,5,6,7-tetrahydrobenzimidazole derivatives
EP0298752B1 (en) Mercapto-substituted pyridine compounds and process for preparing the same
CN110204464B (zh) 一种芳基叔磺酰胺类化合物的合成方法
EP0000301B1 (fr) Procédé de préparation de thiéno(2,3-c) et thiéno(3,2-c) pyridines
SE431643B (sv) Terapeutiskt aktiva halogensubstituerade prolinderivat innehallande svavel och forfarande for deras tillverkning
US20060019995A1 (en) 2,3-dihydro-4(1H)-pyridone derivatives , method for production thereof and pharmaceutical composition comprising the same
EP0156091B1 (de) Beta-Oxo-alpha-carbamoyl-pyrrolpropionitrile, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
KR940005014B1 (ko) 피롤리딘카르복실산 유도체의 제조방법
McKinnon et al. Nucleophilic attack on 2, 1-benzisothiazolium salts
KR100829894B1 (ko) 디메크로트산 및 그의 마그네슘염의 제조방법
CN121914022A (zh) 一种嘧啶衍生物的制备方法及应用